These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 32010914)

  • 1. Stimuli-responsive release and efficient siRNA delivery in non-small cell lung cancer by a poly(l-histidine)-based multifunctional nanoplatform.
    Shi M; Zhang J; Huang Z; Chen Y; Pan S; Hu H; Qiao M; Chen D; Zhao X
    J Mater Chem B; 2020 Feb; 8(8):1616-1628. PubMed ID: 32010914
    [TBL] [Abstract][Full Text] [Related]  

  • 2. pH-responsive hybrid nanoparticle with enhanced dissociation characteristic for siRNA delivery.
    Shi M; Zhao X; Zhang J; Pan S; Yang C; Wei Y; Hu H; Qiao M; Chen D; Zhao X
    Int J Nanomedicine; 2018; 13():6885-6902. PubMed ID: 30498349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Poly(L-histidine) based copolymers: Effect of the chemically substituted L-histidine on the physio-chemical properties of the micelles and in vivo biodistribution.
    Zhang X; Chen D; Ba S; Chang J; Zhou J; Zhao H; Zhu J; Zhao X; Hu H; Qiao M
    Colloids Surf B Biointerfaces; 2016 Apr; 140():176-184. PubMed ID: 26764099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EGF-modified mPEG-PLGA-PLL nanoparticle for delivering doxorubicin combined with Bcl-2 siRNA as a potential treatment strategy for lung cancer.
    Zhang X; Wang Q; Qin L; Fu H; Fang Y; Han B; Duan Y
    Drug Deliv; 2016 Oct; 23(8):2936-2945. PubMed ID: 26739487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancing siRNA-based cancer therapy using a new pH-responsive activatable cell-penetrating peptide-modified liposomal system.
    Xiang B; Jia XL; Qi JL; Yang LP; Sun WH; Yan X; Yang SK; Cao DY; Du Q; Qi XR
    Int J Nanomedicine; 2017; 12():2385-2405. PubMed ID: 28405163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ScFv-decorated PEG-PLA-based nanoparticles for enhanced siRNA delivery to Her2⁺ breast cancer.
    Dou S; Yang XZ; Xiong MH; Sun CY; Yao YD; Zhu YH; Wang J
    Adv Healthc Mater; 2014 Nov; 3(11):1792-803. PubMed ID: 24947820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stimuli-Responsive and Highly Penetrable Nanoparticles as a Multifunctional Nanoplatform for Boosting Nonsmall Cell Lung Cancer siRNA Therapy.
    Shi M; Wang Y; Zhao X; Zhang J; Hu H; Qiao M; Zhao X; Chen D
    ACS Biomater Sci Eng; 2021 Jul; 7(7):3141-3155. PubMed ID: 34137580
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined Delivery of Temozolomide and siPLK1 Using Targeted Nanoparticles to Enhance Temozolomide Sensitivity in Glioma.
    Shi H; Sun S; Xu H; Zhao Z; Han Z; Jia J; Wu D; Lu J; Liu H; Yu R
    Int J Nanomedicine; 2020; 15():3347-3362. PubMed ID: 32494134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stimuli-Responsive Polymer-Prodrug Hybrid Nanoplatform for Multistage siRNA Delivery and Combination Cancer Therapy.
    Saw PE; Yao H; Lin C; Tao W; Farokhzad OC; Xu X
    Nano Lett; 2019 Sep; 19(9):5967-5974. PubMed ID: 31381852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduction sensitive nanocarriers mPEG-g-γ-PGA/SSBPEI@siRNA for effective targeted delivery of survivin siRNA against NSCLC.
    Chen L; Wang S; Liu Q; Zhang Z; Lin S; Zheng Q; Cheng M; Li Y; Cheng C
    Colloids Surf B Biointerfaces; 2020 Sep; 193():111105. PubMed ID: 32417465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor-targeted pH/redox dual-sensitive unimolecular nanoparticles for efficient siRNA delivery.
    Chen G; Wang Y; Xie R; Gong S
    J Control Release; 2017 Aug; 259():105-114. PubMed ID: 28159516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dual-responsive polyplexes with enhanced disassembly and endosomal escape for efficient delivery of siRNA.
    Zhu J; Qiao M; Wang Q; Ye Y; Ba S; Ma J; Hu H; Zhao X; Chen D
    Biomaterials; 2018 Apr; 162():47-59. PubMed ID: 29432988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic delivery of siRNA with cationic lipid assisted PEG-PLA nanoparticles for cancer therapy.
    Yang XZ; Dou S; Sun TM; Mao CQ; Wang HX; Wang J
    J Control Release; 2011 Dec; 156(2):203-11. PubMed ID: 21839126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biodegradable nanoparticles of mPEG-PLGA-PLL triblock copolymers as novel non-viral vectors for improving siRNA delivery and gene silencing.
    Du J; Sun Y; Shi QS; Liu PF; Zhu MJ; Wang CH; Du LF; Duan YR
    Int J Mol Sci; 2012; 13(1):516-533. PubMed ID: 22312268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rational Design of Multifunctional Polymeric Nanoparticles Based on Poly(l-histidine) and d-α-Vitamin E Succinate for Reversing Tumor Multidrug Resistance.
    Li Z; Chen Q; Qi Y; Liu Z; Hao T; Sun X; Qiao M; Ma X; Xu T; Zhao X; Yang C; Chen D
    Biomacromolecules; 2018 Jul; 19(7):2595-2609. PubMed ID: 29618203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The enhancement of siPLK1 penetration across BBB and its anti glioblastoma activity in vivo by magnet and transferrin co-modified nanoparticle.
    Liu DZ; Cheng Y; Cai RQ; Wang Bd WW; Cui H; Liu M; Zhang BL; Mei QB; Zhou SY
    Nanomedicine; 2018 Apr; 14(3):991-1003. PubMed ID: 29339188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. pH/Redox Dual-Responsive Polyplex with Effective Endosomal Escape for Codelivery of siRNA and Doxorubicin against Drug-Resistant Cancer Cells.
    Gao Y; Jia L; Wang Q; Hu H; Zhao X; Chen D; Qiao M
    ACS Appl Mater Interfaces; 2019 May; 11(18):16296-16310. PubMed ID: 30997984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved Cell Transfection of siRNA by pH-Responsive Nanomicelles Self-Assembled with mPEG- b-PHis- b-PEI Copolymers.
    Xu B; Zhu YJ; Wang CH; Qiu C; Sun J; Yan Y; Chen X; Wang JC; Zhang Q
    ACS Appl Mater Interfaces; 2018 Jul; 10(26):21847-21860. PubMed ID: 29882640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comb-like amphiphilic polypeptide-based copolymer nanomicelles for co-delivery of doxorubicin and P-gp siRNA into MCF-7 cells.
    Suo A; Qian J; Zhang Y; Liu R; Xu W; Wang H
    Mater Sci Eng C Mater Biol Appl; 2016 May; 62():564-73. PubMed ID: 26952460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. pH-responsive polymeric sirna carriers sensitize multidrug resistant ovarian cancer cells to doxorubicin via knockdown of polo-like kinase 1.
    Benoit DS; Henry SM; Shubin AD; Hoffman AS; Stayton PS
    Mol Pharm; 2010 Apr; 7(2):442-55. PubMed ID: 20073508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.